These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 19274663)

  • 41. Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern.
    Büllesbach EE; Schwabe C
    Biochem Biophys Res Commun; 1993 Oct; 196(1):311-9. PubMed ID: 8216305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
    Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
    J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Class-B GPCR activation: is ligand helix-capping the key?
    Neumann JM; Couvineau A; Murail S; Lacapère JJ; Jamin N; Laburthe M
    Trends Biochem Sci; 2008 Jul; 33(7):314-9. PubMed ID: 18555686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A structural switch in a mutant insulin exposes key residues for receptor binding.
    Ludvigsen S; Olsen HB; Kaarsholm NC
    J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docking of insulin to a structurally equilibrated insulin receptor ectodomain.
    Vashisth H; Abrams CF
    Proteins; 2010 May; 78(6):1531-43. PubMed ID: 20112420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.
    Wan Z; Xu B; Huang K; Chu YC; Li B; Nakagawa SH; Qu Y; Hu SQ; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Dec; 43(51):16119-33. PubMed ID: 15610006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural Congruency of Ligand Binding to the Insulin and Insulin/Type 1 Insulin-like Growth Factor Hybrid Receptors.
    Menting JG; Lawrence CF; Kong GK; Margetts MB; Ward CW; Lawrence MC
    Structure; 2015 Jul; 23(7):1271-82. PubMed ID: 26027733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The internal symmetry of the primary structure of the beta-subunits of the tyrosine kinase receptors in insulin superfamily peptides and its relation to their functional activity].
    Shpakov AO
    Tsitologiia; 1997; 39(7):590-600. PubMed ID: 9490500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation.
    Ward CW; Menting JG; Lawrence MC
    Bioessays; 2013 Nov; 35(11):945-54, doi/10.1002/bies.201370111. PubMed ID: 24037759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dimerization and negative cooperativity in the relaxin family peptide receptors.
    Svendsen AM; Vrecl M; Knudsen L; Heding A; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Ann N Y Acad Sci; 2009 Apr; 1160():54-9. PubMed ID: 19416159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-based de novo design of ligands using a three-dimensional model of the insulin receptor.
    Tan C; Wei L; Ottensmeyer FP; Goldfine I; Maddux BA; Yip CC; Batey RA; Kotra LP
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1407-10. PubMed ID: 15006372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Conservatism of the insulin signal system in the evolution of vertebrate and invertebrate animals].
    Pertseva MN; Shpakov AO
    Zh Evol Biokhim Fiziol; 2002; 38(5):430-41. PubMed ID: 12575646
    [No Abstract]   [Full Text] [Related]  

  • 55. Receptor binding redefined by a structural switch in a mutant human insulin.
    Hua QX; Shoelson SE; Kochoyan M; Weiss MA
    Nature; 1991 Nov; 354(6350):238-41. PubMed ID: 1961250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The insulin receptor: a prototype for dimeric, allosteric membrane receptors?
    De Meyts P
    Trends Biochem Sci; 2008 Aug; 33(8):376-84. PubMed ID: 18640841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Similar but different: ligand-induced activation of the insulin and epidermal growth factor receptor families.
    Ward CW; Lawrence MC
    Curr Opin Struct Biol; 2012 Jun; 22(3):360-6. PubMed ID: 22521506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin and its receptor: structure, function and evolution.
    De Meyts P
    Bioessays; 2004 Dec; 26(12):1351-62. PubMed ID: 15551269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3).
    Büllesbach EE; Schwabe C
    Biochemistry; 2007 Aug; 46(34):9722-7. PubMed ID: 17676766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review.
    Dunn MF
    Biometals; 2005 Aug; 18(4):295-303. PubMed ID: 16158220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.